GlassScriptPhysician profile
Mary E Albright
NPI 1124293709
$872.65
in general payments reported to CMS, 2019-2025
14 companies · $38.61 in 2025
The $38.61 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.20 · 2022: $170 · 2023: $407 · 2024: $169 · 2025: $38.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $204.38 | 2021-2023 | Ztlido |
| Medtronic, INC. | $134.19 | 2023-2024 | Mazor X System, Plasmablade(Tm), Aquamantys(Tm) |
| Biotronik Nro, INC. | $128.76 | 2024-2025 | Prospera |
| Boston Scientific Corporation | $76.42 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $55.08 | 2023 | Everest Spinal System, Xia 3 |
| Djo, LLC | $54.89 | 2023 | Cmf |
| Collegium Pharmaceutical, INC. | $53.98 | 2022-2024 | Xtampza |
| Si-Bone, INC. | $52.50 | 2022 | |
| Ibsa Pharma INC. | $30.31 | 2023 | Tirosint, Licart |
| Kci USA, INC. | $22.83 | 2023 | Prevena |
| Saluda Medical Americas, INC. | $15.86 | 2023 | Evoke Scs |
| Elevation Spine, INC. | $15.48 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $14.94 | 2021 | |
| Relievant Medsystems, INC. | $13.03 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Albright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.